After a long latent period since its discovery by Lawrence in 1955 (Lawrence 1955) , transfer factor (TF) has recently moved into the limelight as the antigenspecific initiator of cell-mediated immunity and has been widely applied with promissing results to the treatment of a variety of immunodeficiency diseases (Levin et al. 1970 ; Spitler et al. 1972 ; Ammann et al. 1974 ; Ballow and Good 1975) , intracellular infections (Schulkind et al. 1972; Graybill et al. 1973; Wolf et al. 1978) , and malignancies (Brandes et al. 1971; Oettgen et al. 1974 ). However, its character or mode of action is little understood because TF phenomenon, though easily demonstrated in humans in vivo, has been detected with difficulty in experimental animals (Lawrence 1969) : even the very promising results obtained with DNCB-sensitized guinea pigs have not been reproducible (Dressler and Potter 1975) . The clinical application of TF is, therefore, dependent on nothing but empiricism and the establishment of an animal model system is needed before the clarification of the properties and mechanism of the action of TF can be made.
We have investigated several combinations of animals and antigens in order
to establish an animal model system and have discovered TF activity in a fraction extracted from the spleens of sensitized mice. This paper reports the properties and possible mechanism of action of this material. Response to naive TF of normal mice Three groups each comprising 5 normal mice were given i .p. different doses of spleen extract from unsensitized mice (termed naive TF) , which were prepared by the same procedure as TF, and were footpad tested , as described above. Six untreated mice and 2 mice given TF prepared from the spleens of 2 .5 BCG-sensitized mice served as negative and positive controls , respectively. Though BCG-TF exerted an effect (p<0.001), naive TF was found to be inactive (no significant dif ference was observed at the 20% level) ( Table 1) . TF activity was, therefore, detectable only in the spleen extracts from the sensitized animals.
MATERIALS AND METHODS

Dose response to TF
The relationship was examined between the dose of TF and the magnitude of the sensitivity transferred to the recipients. Four groups of 2-7 normal mice received different doses of TF from BCG-sensitized mice and were footpad tested, as described above. Three BCG-sensitized and 8 normal mice served as positive and negative controls, respectively. Fig. 2 shows the more TF given, the stronger the sensitivity transferred. TF prepared from 3 spleens gave the same degree of sensitivity as was observed in the BCG-sensitized mice (no difference was observed at the 50% level) and TF prepared from 5 or more spleens conferred stronger sensitivity (p<0.005).
Heat-stability of TF another 10 mice were injected i.p. with TF prepared from the spleens of 5 BCGsensitized mice and were divided into two groups and tested with either antigen, as mentioned above. Table 3 shows that the mice given Candida-TF responded to an eliciting injection of Candida, while those receiving BCG-TF showed only little reaction to that antigen (p<0.025). In the same manner the recipients of BCG-TF mounted a significantly greater response to a challenging injection of BCG than those that received Candida-TF (p<0.001). TF was, therefore, shown to confer an antigen-specific immunological memory upon a recipient.
Response of nude mice to TF fraction. Five untreated mice served as negative controls. They were then footpad tested with BCG. Table 6 shows that the activity was detected only in the first fraction (p<0.001), which was eluted just after the void volume, while the second fraction showed no statistically significant activity as compared with the control. UV spectrum of the active principle Fig. 6 shows the UV spectrum of the active principle obtained by gel filtration on Sephadex G-15. It was shown to have a maximum absorbancy at 249 nm and to have an 0D260/0D280 ratio of 9:1. In addition it was found to be orcinol positive . It was, therefore, considered to be a substance containing nucleic acids . DISCUSSION Chase (1945) demonstrated that specific delayed type hypersensitivity was transferred to unsensitized guinea pigs by the injection of peritoneal exudative leukocytes from sensitized guinea pigs, thus achieving a distinct separation of the category of immune responses initiated by cells from that of those mediated by immunoglobulins. Reproducing the phenomenon in humans with viable blood leukocytes (Lawrence 1949 ), Lawrence (1955) observed later that leukocyte extracts were as effective as viable cells. Such leukocyte extracts, viz., TF, as the name indicates, is thought of as a substance that transfers a specific memory of cell-mediated immunity from a sensitive donor to a naive recipient.
However, TF fraction has recently been shown to have many other activities, such as nonspecific conversion of lymphocytes in vitro (Miller et al. 1977) , augmentation of lymphocyte transformation responses to PPD (Hamblin et al. 1976a ) and to PHA in vitro (Hamblin et al. 1976b ), chemotactic activity in vitro (Gallin and Kirkpatrick 1974) , nonspecific augmentation of thymidine incorporation of an antigen-specific precommitted clone of lymphocytes (Cohen et al. 1976 ), stimulatory or inhibitory effects on lymphocyte transformation in vitro (Burger et al. 1976a) , and both specific and nonspecific augmetation of lymphocyte transformation in vitro (Burger et al. 1976b; Littman et al. 1977) . This is partly because TF is not a single substance but a mixture of chemically heterogeneous dialyzable molecules apparently possessing different biological effects. Some of these activities were not detected in the more purified fraction having classical TF activity (Burger et al. 1976; Littman et al. 1977 ) and augmentation of 3H-thymidine incorporation by lymphocytes in vitro in the presense of dialyzable TF (TFd) is not a measure of TF activity (Littman et al. 1977) . The relationship between other activities in vitro and the classical TF activity in vivo remains to be clarified ( We regard the classical TF activity as the marker of activity TF possesses. We suspect that TF is not an artifact but a physiological substance with a teleological raison d'etre endowed by Nature: it exercises its activity in the intercellular milieu in an individual. As the cellular transfer of delayed type hypersensitivity can be accomplished in rodents, there is no room for doubt that Nature has also bestowed such a substance upon vertebrates other than humans. The misfortunes that have dogged the animal experimental systems previously described cannot be due to the nonexistence of TF in nonhuman vertebrates.
On such a premise, we investigated several combinations of animals and antigens to find an animal model and finally succeeded in showing TF-like activity in a fraction extracted from the spleens of BCG-sensitized mice (Fig. 1) . This frac tion was identified as possessing TF on the basis of the following characteristics: the fraction from BCG-sensitized mice imparted BCG-sensitivity to naive recipients within 24 hr, whereas the same fraction prepared from unsensitized mice did not (Table 1) ; the active fraction transferred antigen-specific delayed type hypersensitivity to recipients (Table 3) .
We found the TF activity to be relatively heat-stable (Table 2) . Gel filtration of the substance on Sephadex G-25 and G-15 columns and the UV spectrum showed it to consist of a principal component of ca 1,000 daltons molecular weight, apparently containing nucleic acids (Figs. 4, 5 and 6) .
TF in human is generally considered to be an extract from educated lymphocytes made up of a peptide-RNA nucleotide complex of less than 10,000 molecular weight, which transmits to a naive recipient an immunologically specific, long-lasting memory of cell-mediated immunity (Kirkpatrick and Rifkind 1974) . Our results, as described above, are in general accordance with this consensus.
Many investigators have shown that gel filtration of human TFd on Sephadex G-25 termed TFc or TFg produces a biologically active fraction with a character istic effluent volume and high 260 nm/280 nm ratio (Zuckerman et al. 1974; O'Dorisio et al. 1976; Tomar et al. 1976 ). Such a fraction was considered to contain hypoxanthine as a major component (O'Dorisio et al. 1976; Tomar et al. 1976) . This was later shown not to be responsbile for the TF activity in vivo (Kirkpatrick et al. 1976 ). In addition, hypoxanthine was found to separate from the active subfraction of TFg designated as Tx which does not have a high 260 nm/280 nm (Wilson et al. 1977 ). The precise character of Tx remains to be elucidated.
We demonstrated that mouse TF also has a characteristically high 260 nm/ 280 nm ratio which elutes just before the total bed volume on Sephadex G-25 and just after the void volume on Sephadex G-15. UV absorbance spectroscopy showed that mouse TF has a maximum absorbance at 249 nm at neutral pH, while TFg and hypoxanthine were shown to have their maximum absorption at 251 nm (Wilson et al. 1977) . Also mouse TF was found to be orcinol positive . These data suggested that mouse TF was very similar to human TFg or TFc . Further purification of mouse TF is necessary. As it is the critical lack of an experimental animal model that has hampered the study of TF , the experimental system we have established will make a contribution to the further investigation of TF .
The consensus on human TF led us to a hypothesis that TF acts upon thymus derived cells to trigger their differentiation , which is completed within 24 hr and, therefore, requires no cell division. To test the validity of this hypothesis , we examined whether TF caused conversion in nude , congenitally athymic mice, and observed that they did not respond to TF administration . In accord with our finding, Lawlor et al. (1974) reported that 3 patients with a probable diagnosis of Nezelof syndrome did not respond to TF administration either immunologically or clinically. In addition, Pachmann et al . (1974) observed the lack of effect of TF in 4 children with thymic dysplasia with normal Ig synthesis and allegedly attributed the observation to the absense of thymus-influenced lymphocytes in these patients . Further, we demonstrated that the unresponsiveness to TF in nude mice was abolished by the introduction of viable spleen cells . Taken together , these results, though preliminary, strongly support our hypothesis and suggest that the thymus plays a key role in the expression of the TF phenomenon and that the target of TF is the T cells. Arala-Chaves et al. (1976) drew the same conclusion from in vitro studies.
We observed a dose response effect of TF. This finding indicates that TF gives rise to a graded rather than all-or-none response. Indeed, the recipients given TF prepared from 5 or more spleens showed a greater magnitude of response than that observed in antigen-sensitized animals. Ascher et al. (1974) also reported a doseresponse effect of TF in the presense of a constant concentration of a specific antigen in vitro. These data suggest that TF exerts its effect on a reservoir of virgin T cells in a recipient to generate a new clone of T cells reactive to a specific antigen within 24 hr and that, in proportion to the dose, it expands the clone, even to such a degree that the clone produced de novo by TF exceeds that in an antigen-sensitized animal.
Gel chromatography and the UV absorption spectrum of TF revealed that it is a substance of ca 1,000 molecular weight, seemingly containing nucleic acids. How can a nucleic acid, too small to code for the protein which is presumably involved in antigen recognition, transmit information for a specific immune response that generates and expands a new clone of specific T cells in such a short time ? It is hardly conceivable that a particular population of T cells could proliferate to such an extent that it could elicit a secondary response within 24 hr. We consider it more likely that TF converts a population of T cells preprogrammed to react to a certain antigen into an antigen-responsive state without inducing it to proliferate. Then TF, as Pappenheimer (1957) postulated, might be considered to be a specific T cell receptor itself, which adheres to naive T cells to make it reactive to a specific antigen. An alternative candidate for the identity of TF is, as suggested by Lawrence (1969) , a derepressor, which switches on a clone of T cells already destined to respond to a specific antigen.
It was confirmed earlier that, upon contact with a given antigen in vitro, the educated lymphocytes promptly released the monospecific TF (Lawrence and Pappenheimer 1957; Graybill et al. 1973 ). Feldmann et al. (1973) provided the evidence that the primed carrier-reactive T cells actively shed the antigen-specific T cell factor, which cytophilically binds to macrophages to help hapten-reactive B cells make an anti-hapten response. In analogy to this, it is likely that the monospecific TF released by the educated lymphocytes converts naive T cells into com mitted cells in vivo.
We think it teleologically appropriate that TF, whether it be a receptor or a derepressor, is released by the educated lymphocytes which have just reacted to antigens and that it, by converting naive cells, expands the specific clone so as to successfully defend the host against invading pathogens or anything recognized as not-self.
The exact character and the mechanism of action of TF remain to be elucidated.
